1023 related articles for article (PubMed ID: 31074810)
1. Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment.
Wu A; Sharrett AR; Gottesman RF; Power MC; Mosley TH; Jack CR; Knopman DS; Windham BG; Gross AL; Coresh J
JAMA Netw Open; 2019 May; 2(5):e193359. PubMed ID: 31074810
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
[TBL] [Abstract][Full Text] [Related]
3. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting.
Roberts RO; Aakre JA; Kremers WK; Vassilaki M; Knopman DS; Mielke MM; Alhurani R; Geda YE; Machulda MM; Coloma P; Schauble B; Lowe VJ; Jack CR; Petersen RC
JAMA Neurol; 2018 Aug; 75(8):970-979. PubMed ID: 29710225
[TBL] [Abstract][Full Text] [Related]
5. Periventricular white matter hyperintensities and the risk of dementia: a CREDOS study.
Kim S; Choi SH; Lee YM; Kim MJ; Kim YD; Kim JY; Park JH; Myung W; Na HR; Han HJ; Shim YS; Kim JH; Yoon SJ; Kim SY; Kim DK
Int Psychogeriatr; 2015 Dec; 27(12):2069-77. PubMed ID: 26212042
[TBL] [Abstract][Full Text] [Related]
6. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
[TBL] [Abstract][Full Text] [Related]
7. Alcohol Consumption and Risk of Dementia and Cognitive Decline Among Older Adults With or Without Mild Cognitive Impairment.
Koch M; Fitzpatrick AL; Rapp SR; Nahin RL; Williamson JD; Lopez OL; DeKosky ST; Kuller LH; Mackey RH; Mukamal KJ; Jensen MK; Sink KM
JAMA Netw Open; 2019 Sep; 2(9):e1910319. PubMed ID: 31560382
[TBL] [Abstract][Full Text] [Related]
8. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
[TBL] [Abstract][Full Text] [Related]
9. Brain imaging correlates of mild cognitive impairment and early dementia in patients with type 2 diabetes mellitus.
Groeneveld O; Reijmer Y; Heinen R; Kuijf H; Koekkoek P; Janssen J; Rutten G; Kappelle L; Biessels G;
Nutr Metab Cardiovasc Dis; 2018 Dec; 28(12):1253-1260. PubMed ID: 30355471
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities.
Burke SL; Hu T; Fava NM; Li T; Rodriguez MJ; Schuldiner KL; Burgess A; Laird A
J Women Aging; 2019; 31(2):140-164. PubMed ID: 29319430
[TBL] [Abstract][Full Text] [Related]
11. The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer's Disease.
Horvath A; Quinlan P; Eckerström C; Åberg ND; Wallin A; Svensson J
J Alzheimers Dis; 2024; 99(2):609-622. PubMed ID: 38701139
[TBL] [Abstract][Full Text] [Related]
12. MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.
Ten Kate M; Redolfi A; Peira E; Bos I; Vos SJ; Vandenberghe R; Gabel S; Schaeverbeke J; Scheltens P; Blin O; Richardson JC; Bordet R; Wallin A; Eckerstrom C; Molinuevo JL; Engelborghs S; Van Broeckhoven C; Martinez-Lage P; Popp J; Tsolaki M; Verhey FRJ; Baird AL; Legido-Quigley C; Bertram L; Dobricic V; Zetterberg H; Lovestone S; Streffer J; Bianchetti S; Novak GP; Revillard J; Gordon MF; Xie Z; Wottschel V; Frisoni G; Visser PJ; Barkhof F
Alzheimers Res Ther; 2018 Sep; 10(1):100. PubMed ID: 30261928
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
[TBL] [Abstract][Full Text] [Related]
14. Vascular Risk Factors, Vascular Diseases, and Imaging Findings in a Hospital-based Cohort of Mild Cognitive Impairment Types.
Camarda C; Pipia C; Azzarello D; Battaglini I; Romeo G; Chiodi M; Camarda R
Curr Alzheimer Res; 2018; 15(7):679-690. PubMed ID: 29357798
[TBL] [Abstract][Full Text] [Related]
15. Body Mass Index Trajectories Preceding Incident Mild Cognitive Impairment and Dementia.
Guo J; Wang J; Dove A; Chen H; Yuan C; Bennett DA; Xu W
JAMA Psychiatry; 2022 Dec; 79(12):1180-1187. PubMed ID: 36287554
[TBL] [Abstract][Full Text] [Related]
16. Predictors of progression from mild cognitive impairment to dementia in the placebo-arm of a clinical trial population.
Prins ND; van der Flier WM; Brashear HR; Knol DL; van de Pol LA; Barkhof F; Scheltens P
J Alzheimers Dis; 2013; 36(1):79-85. PubMed ID: 23563246
[TBL] [Abstract][Full Text] [Related]
17. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
18. Arterial stiffness and dementia pathology: Atherosclerosis Risk in Communities (ARIC)-PET Study.
Hughes TM; Wagenknecht LE; Craft S; Mintz A; Heiss G; Palta P; Wong D; Zhou Y; Knopman D; Mosley TH; Gottesman RF
Neurology; 2018 Apr; 90(14):e1248-e1256. PubMed ID: 29549223
[TBL] [Abstract][Full Text] [Related]
19. Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.
Krell-Roesch J; Vemuri P; Pink A; Roberts RO; Stokin GB; Mielke MM; Christianson TJ; Knopman DS; Petersen RC; Kremers WK; Geda YE
JAMA Neurol; 2017 Mar; 74(3):332-338. PubMed ID: 28135351
[TBL] [Abstract][Full Text] [Related]
20. White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort.
Prasad K; Wiryasaputra L; Ng A; Kandiah N
Dement Geriatr Cogn Disord; 2011; 31(6):431-4. PubMed ID: 21757908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]